241 related articles for article (PubMed ID: 20662941)
1. Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism.
Correia CT; Coutinho AM; Sequeira AF; Sousa IG; Lourenço Venda L; Almeida JP; Abreu RL; Lobo C; Miguel TS; Conroy J; Cochrane L; Gallagher L; Gill M; Ennis S; Oliveira GG; Vicente AM
Genes Brain Behav; 2010 Oct; 9(7):841-8. PubMed ID: 20662941
[TBL] [Abstract][Full Text] [Related]
2. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism.
Nishimura K; Nakamura K; Anitha A; Yamada K; Tsujii M; Iwayama Y; Hattori E; Toyota T; Takei N; Miyachi T; Iwata Y; Suzuki K; Matsuzaki H; Kawai M; Sekine Y; Tsuchiya K; Sugihara G; Suda S; Ouchi Y; Sugiyama T; Yoshikawa T; Mori N
Biochem Biophys Res Commun; 2007 Apr; 356(1):200-6. PubMed ID: 17349978
[TBL] [Abstract][Full Text] [Related]
4. Is autism caused by early hyperactivity of brain-derived neurotrophic factor?
Tsai SJ
Med Hypotheses; 2005; 65(1):79-82. PubMed ID: 15893122
[TBL] [Abstract][Full Text] [Related]
5. The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.
Juhasz G; Dunham JS; McKie S; Thomas E; Downey D; Chase D; Lloyd-Williams K; Toth ZG; Platt H; Mekli K; Payton A; Elliott R; Williams SR; Anderson IM; Deakin JF
Biol Psychiatry; 2011 Apr; 69(8):762-71. PubMed ID: 21215389
[TBL] [Abstract][Full Text] [Related]
6. Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression.
Lin E; Hong CJ; Hwang JP; Liou YJ; Yang CH; Cheng D; Tsai SJ
Rejuvenation Res; 2009 Dec; 12(6):387-93. PubMed ID: 20014955
[TBL] [Abstract][Full Text] [Related]
7. Contribution of NTRK2 to the genetic susceptibility to anorexia nervosa, harm avoidance and minimum body mass index.
Ribases M; Gratacos M; Badia A; Jimenez L; Solano R; Vallejo J; Fernandez-Aranda F; Estivill X
Mol Psychiatry; 2005 Sep; 10(9):851-60. PubMed ID: 15838534
[TBL] [Abstract][Full Text] [Related]
8. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia.
Mercader JM; Ribasés M; Gratacòs M; González JR; Bayés M; de Cid R; Badía A; Fernández-Aranda F; Estivill X
Genes Brain Behav; 2007 Nov; 6(8):706-16. PubMed ID: 17376155
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy.
Connolly AM; Chez M; Streif EM; Keeling RM; Golumbek PT; Kwon JM; Riviello JJ; Robinson RG; Neuman RJ; Deuel RM
Biol Psychiatry; 2006 Feb; 59(4):354-63. PubMed ID: 16181614
[TBL] [Abstract][Full Text] [Related]
10. Placental BDNF/TrkB signaling system is modulated by fetal growth disturbances in rat and human.
Mayeur S; Silhol M; Moitrot E; Barbaux S; Breton C; Gabory A; Vaiman D; Dutriez-Casteloot I; Fajardy I; Vambergue A; Tapia-Arancibia L; Bastide B; Storme L; Junien C; Vieau D; Lesage J
Placenta; 2010 Sep; 31(9):785-91. PubMed ID: 20615547
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder.
Murphy ML; Carballedo A; Fagan AJ; Morris D; Fahey C; Meaney J; Frodl T
Biol Psychiatry; 2012 Oct; 72(8):663-70. PubMed ID: 22609366
[TBL] [Abstract][Full Text] [Related]
12. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations.
Ribasés M; Gratacòs M; Fernández-Aranda F; Bellodi L; Boni C; Anderluh M; Cristina Cavallini M; Cellini E; Di Bella D; Erzegovesi S; Foulon C; Gabrovsek M; Gorwood P; Hebebrand J; Hinney A; Holliday J; Hu X; Karwautz A; Kipman A; Komel R; Nacmias B; Remschmidt H; Ricca V; Sorbi S; Tomori M; Wagner G; Treasure J; Collier DA; Estivill X
Eur J Hum Genet; 2005 Apr; 13(4):428-34. PubMed ID: 15657604
[TBL] [Abstract][Full Text] [Related]
13. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.
Coutinho AM; Oliveira G; Morgadinho T; Fesel C; Macedo TR; Bento C; Marques C; Ataíde A; Miguel T; Borges L; Vicente AM
Mol Psychiatry; 2004 Mar; 9(3):264-71. PubMed ID: 15094787
[TBL] [Abstract][Full Text] [Related]
14. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Szczepankiewicz A; Hauser J
Pharmacogenomics; 2008 Nov; 9(11):1595-603. PubMed ID: 19018715
[TBL] [Abstract][Full Text] [Related]
15. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism.
Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suzuki K; Minabe Y; Takei N; Iyo M; Mori N
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1529-31. PubMed ID: 16876305
[TBL] [Abstract][Full Text] [Related]
16. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
Correia CT; Almeida JP; Santos PE; Sequeira AF; Marques CE; Miguel TS; Abreu RL; Oliveira GG; Vicente AM
Pharmacogenomics J; 2010 Oct; 10(5):418-30. PubMed ID: 19997080
[TBL] [Abstract][Full Text] [Related]
18. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.
Sklar P; Gabriel SB; McInnis MG; Bennett P; Lim Y-; Tsan G; Schaffner S; Kirov G; Jones I; Owen M; Craddock N; DePaulo JR; Lander ES
Mol Psychiatry; 2002; 7(6):579-93. PubMed ID: 12140781
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample.
Strauss J; Barr CL; George CJ; Devlin B; Vetró A; Kiss E; Baji I; King N; Shaikh S; Lanktree M; Kovacs M; Kennedy JL
Mol Psychiatry; 2005 Sep; 10(9):861-7. PubMed ID: 15940299
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.
Fujimura H; Altar CA; Chen R; Nakamura T; Nakahashi T; Kambayashi J; Sun B; Tandon NN
Thromb Haemost; 2002 Apr; 87(4):728-34. PubMed ID: 12008958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
